Invesco Global Focus C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Invesco Global Focus Fund Class C GLVCX
- NAV / 1-Day Return 71.28 / −0.31 %
- Total Assets 570.2M
-
Adj. Expense Ratio
1.980%
- Expense Ratio 1.980%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 17%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GLVCX
Will GLVCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the GLVCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of GLVCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 56.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class A | 12.42 | 68M | Communication Services |
Amazon.com Inc | 7.31 | 40M | Consumer Cyclical |
Taiwan Semiconductor Manufacturing Co Ltd | 6.82 | 37M | Technology |
Meta Platforms Inc Class A | 5.90 | 32M | Communication Services |
Broadcom Inc | 5.50 | 30M | Technology |
NVIDIA Corp | 4.25 | 23M | Technology |
Lam Research Corp | 4.04 | 22M | Technology |
Mastercard Inc Class A | 3.87 | 21M | Financial Services |
Visa Inc Class A | 3.36 | 18M | Financial Services |
Thermo Fisher Scientific Inc | 3.18 | 17M | Healthcare |
United States